Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Merotocin for inadequate milk production in preterm mothers
NCT02545127Phase 2Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- May 2021
- Primary completion
- Nov 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of merotocin in hypogalactia, sponsored by Ferring Pharmaceuticals. Started May 2021; status: terminated.
02
Drugs
merotocin
03
Conditions
hypogalactia
Beyond the preview
Go deeper on NCT02545127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545127.